Kezar Life Sciences, Inc.KZRNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank67
3Y CAGR-4.3%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
-4.3%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$1.04M-34.8%
2024$1.59M+2.8%
2023$1.55M+30.8%
2022$1.19M+645.3%
2021$159000.00-
2020$0.00-
2019$0.00-
2018$0.00-
2017$0.00-
2016$0.00-